Federal agencies may be cracking down on private equity investment in health care, which could have implications for behavioral health dealmaking in the future. In early March, the Federal Trade Commission, the Department of Justice’s (DOJ) Antitrust Division, and the U.S. Department of Health and Human Services launched a new investigation into private equity and […]
Despite the sky-high interest rates, this could be the prime time for behavioral health acquisitions. The demand for services remains high and the elevated interest rates mean that valuations are coming back down to earth. While de novo growth strategies have dominated the behavioral health domain in 2023, some investors see this moment as an […]
By continuing to use the site, you agree to the use of cookies. more information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.
